- Author:
Junghyun NOH
1
Author Information
- Publication Type:Original Article
- Keywords: Glycemic control; Diabetic nephropathy
- MeSH: Diabetes Mellitus; Diabetic Nephropathies; Humans; Hypoglycemic Agents; Incidence; Kidney; Renal Insufficiency, Chronic
- From:Journal of Korean Diabetes 2013;14(1):23-26
- CountryRepublic of Korea
- Language:Korean
- Abstract: Diabetes mellitus is a leading cause of kidney disease; nearly one-third of patients with diabetes develop nephropathy. Several trials assessed the effect of intensive glycemic control in diabetic patients and provided strong evidence that intensive therapy reduces the incidence and progression of diabetic nephropathy, especially microalbuminuria, an early marker of diabetic nephropathy. The presence of impaired kidney function should influence selection, dosing, and monitoring of hypoglycemic agents. This article reviews the effects of intensive glycemic control on the development and progression of diabetic nephropathy and the clinical use of antidiabetic therapies in patients with chronic kidney disease.